Report

rss

Iraq News

Kurdistan

Economy

World

All News

Coronavirus: Oxford-AstraZeneca vaccine 'behaves as desired', analysis finds

Category: World

Date: 2020-10-22T17:04:43+0000
Coronavirus: Oxford-AstraZeneca vaccine 'behaves as desired', analysis finds

Shafaq news/ (Sky News) The COVID-19 vaccine being developed by Oxford University and AstraZeneca has been shown to work as planned by new analysis. 

A method to check the inoculation contains all the correct parts was developed by a team at Bristol University, providing greater evidence that the vaccine works.

Even though the research has not yet been peer reviewed, it has been hailed as a "wonderful example of cross-disciplinary collaboration".

The vaccine is currently undergoing Phase 3 clinical trials to further establish the safety of the treatment.

It comes after confirmation the trials will continue after a man taking part died in Brazil. It is understood that the man was taking a placebo and not the active vaccine.

The new method of analysis allowed scientists to check that the vaccine was properly designed to replicate the parts of the COVID-19 make-up needed to train the immune system to fight the disease.

The study proved that the vaccine is correctly programmed to replicate the "spike protein" associated with COVID-19 that has been inserted into the immunization shot.

This protein is what the body's immune system will learn to attack - providing people with the biological tools needed to battle the virus.

Dr David Matthews, of Bristol's School of Cellular and Molecular Medicine, who led the research, said: "This is an important study as we are able to confirm that the genetic instructions underpinning this vaccine, which is being developed as fast as safely possible, are correctly followed when they get into a human cell.

"Until now, the technology hasn't been able to provide answers with such clarity, but we now know the vaccine is doing everything we expected and that is only good news in our fight against the illness."

Sarah Gilbert, professor of vaccinology at the University of Oxford and lead on the Oxford vaccine trial, added: "This is a wonderful example of cross-disciplinary collaboration, using new technology to examine exactly what the vaccine does when it gets inside a human cell.

"The study confirms that large amounts of the coronavirus spike protein are produced with great accuracy, and this goes a long way to explaining the success of the vaccine in inducing a strong immune response."


related

Europe Had 50% Excess Mortality at Outbreak Peak

Date: 2020-07-29 19:07:30
Europe Had 50% Excess Mortality at Outbreak Peak

Covid-19: 'Major incident' declared by London Mayor Sadiq Khan

Date: 2021-01-08 18:35:58
Covid-19: 'Major incident' declared by London Mayor Sadiq Khan

WHO: 10% of world's people may have been infected with virus

Date: 2020-10-05 13:33:51
WHO: 10% of world's people may have been infected with virus

Turkey records highest COVID-19 cases since beginning of pandemic

Date: 2021-03-31 18:18:45
Turkey records highest COVID-19 cases since beginning of pandemic

Covid-19: A New and Pretty Scary discovery

Date: 2020-08-20 15:18:11
Covid-19: A New and Pretty Scary discovery

Autocratic regimes obscure COVID-19's actual mortality counts, international study suggests

Date: 2021-08-08 18:37:07
Autocratic regimes obscure COVID-19's actual mortality counts, international study suggests

India Records World’s Highest One-Day Surge in COVID-19 Cases

Date: 2021-04-22 10:44:18
India Records World’s Highest One-Day Surge in COVID-19 Cases

How life to return to normal after Covid-19 vaccine

Date: 2020-08-28 12:46:54
How life to return to normal after Covid-19 vaccine